TD Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$87M Sell
1,004,587
-38,016
-4% -$3.64M 0.07% 211
2025
Q4
$100M Sell
1,042,603
-74,610
-7% -$7.25M 0.08% 196
2025
Q3
$106M Sell
1,117,213
-56,771
-5% -$5.22M 0.09% 194
2025
Q2
$102M Sell
1,173,984
-111,195
-9% -$9.43M 0.09% 190
2025
Q1
$115M Buy
1,285,179
+20,210
+2% +$1.81M 0.11% 174
2024
Q4
$101M Buy
1,264,969
+161,998
+15% +$14M 0.09% 196
2024
Q3
$98.5M Buy
1,102,971
+32,276
+3% +$2.72M 0.09% 205
2024
Q2
$84.3M Buy
1,070,695
+33,634
+3% +$2.76M 0.08% 215
2024
Q1
$90.4M Buy
1,037,061
+2,847
+0.3% +$243K 0.08% 216
2023
Q4
$85.2M Buy
1,034,214
+42,988
+4% +$3.28M 0.08% 205
2023
Q3
$77.7M Buy
991,226
+7,092
+0.7% +$594K 0.09% 173
2023
Q2
$86.7M Sell
984,134
-300,724
-23% -$25.9M 0.1% 157
2023
Q1
$104M Buy
1,284,858
+119,984
+10% +$9.78M 0.13% 143
2022
Q4
$90.5M Buy
1,164,874
+165,342
+17% +$13.4M 0.11% 154
2022
Q3
$82.2M Sell
999,532
-628,385
-39% -$56.5M 0.1% 156
2022
Q2
$146M Buy
1,627,917
+94,668
+6% +$9.59M 0.17% 109
2022
Q1
$170M Buy
1,533,249
+106,671
+7% +$11.3M 0.16% 121
2021
Q4
$148M Sell
1,426,578
-2,621,023
-65% -$304M 0.12% 146
2021
Q3
$507M Buy
4,047,601
+157,869
+4% +$20.4M 0.53% 36
2021
Q2
$511M Buy
3,889,732
+994,626
+34% +$125M 0.52% 39
2021
Q1
$342M Buy
2,895,106
+402,966
+16% +$47.2M 0.38% 58
2020
Q4
$292M Buy
2,492,140
+409,106
+20% +$45M 0.35% 67
2020
Q3
$216M Sell
2,083,034
-150,821
-7% -$15.1M 0.3% 77
2020
Q2
$205M Buy
2,233,855
+61,565
+3% +$5.9M 0.29% 76
2020
Q1
$196M Buy
2,172,290
+222,589
+11% +$23.7M 0.33% 63
2019
Q4
$221M Buy
1,949,701
+31,523
+2% +$3.46M 0.32% 66
2019
Q3
$208M Buy
1,918,178
+252,617
+15% +$26.4M 0.32% 70
2019
Q2
$162M Sell
1,665,561
-36,074
-2% -$3.29M 0.24% 81
2019
Q1
$155M Buy
1,701,635
+199,781
+13% +$17.9M 0.24% 82
2018
Q4
$137M Buy
1,501,854
+114,875
+8% +$10.7M 0.24% 79
2018
Q3
$136M Sell
1,386,979
-94,270
-6% -$8.72M 0.2% 89
2018
Q2
$127M Buy
1,481,249
+19,401
+1% +$1.62M 0.19% 98
2018
Q1
$117M Buy
1,461,848
+92,923
+7% +$7.66M 0.18% 105
2017
Q4
$111M Sell
1,368,925
-30,558
-2% -$2.45M 0.16% 111
2017
Q3
$109M Sell
1,399,483
-33,924
-2% -$2.82M 0.16% 113
2017
Q2
$127M Buy
1,433,407
+34,543
+2% +$2.91M 0.2% 95
2017
Q1
$113M Buy
1,398,864
+59,520
+4% +$4.65M 0.18% 103
2016
Q4
$95.4M Sell
1,339,344
-208,597
-13% -$16.4M 0.16% 110
2016
Q3
$134M Sell
1,547,941
-46,391
-3% -$4.04M 0.23% 86
2016
Q2
$138M Buy
1,594,332
+100,071
+7% +$8.09M 0.25% 82
2016
Q1
$112M Buy
+1,494,261
New +$113M 0.21% 94
2015
Q1
Sell
-737,815
Closed -$53.3M 1393
2014
Q4
$53.3M Sell
737,815
-1,557
-0.2% -$108K 0.09% 172
2014
Q3
$45.8M Sell
739,372
-5,073
-0.7% -$323K 0.08% 185
2014
Q2
$47.5M Sell
744,445
-300
-0% -$18.2K 0.08% 179
2014
Q1
$45.8M Buy
744,745
+38,590
+5% +$2.25M 0.08% 177
2013
Q4
$40.5M Buy
706,155
+8,525
+1% +$483K 0.08% 182
2013
Q3
$37.1M Sell
697,630
-16,146
-2% -$869K 0.07% 188
2013
Q2
$36.7M Buy
+713,776
New +$35.3M 0.08% 178

Other funds holding MDT

TD Asset Management's MDT Position: Q1 2026 in Review

TD Asset Management reduced its Medtronic (MDT) stake by 3.6% in Q1 2026, selling an estimated $3.64M and leaving 1,004,587 shares worth $87M. The position accounts for 0.07% of the portfolio, ranked #211.

TD Asset Management first reported a position in MDT in Q2 2013 and has held it in 48 quarters since. The position peaked at $511M in Q2 2021. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • TD Asset Management held 1,004,587 shares of Medtronic worth $87M as of Q1 2026.
  • TD Asset Management sold 38,016 Medtronic shares in Q1 2026, an estimated $3.64M.
  • Medtronic made up 0.07% of TD Asset Management's portfolio in Q1 2026, its #211 holding.
  • TD Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 48 quarters since.
  • TD Asset Management's Medtronic position peaked at $511M in Q2 2021.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on TD Asset Management's 13F filing for Q1 2026, filed 11 May 2026.